Pediatric Adverse Event Reporting Could Improve With Claims Database Analysis
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Pediatric Advisory Committee says the easiest short-term remedy for improving the quality of the agency’s adverse event reporting system would be claims database analysis, although the best method would be population-based active surveillance.